Maddy summaryThe STOP Scams Against Seniors Act directs federal Byrne funds to create elder justice task forces focused on preventing and investigating financial scams targeting seniors aged 60 and older. These task forces must coordinate with local law enforcement, prosecutors, and federal agencies like the FBI and FTC to address fraud. Grantees must report detailed data on cases opened, resolved, victims supported, scam types, and signs of organized crime, with the Attorney General submitting an annual summary to Congress. The bill directly affects seniors vulnerable to financial exploitation and the agencies implementing these task forces.
Rep. Eric Sorensen
Sponsored bills
Maddy summaryThis bill establishes a permanent tuition assistance program for Air National Guard members. It requires the Air Force Secretary to pay all or part of tuition and fees at educational institutions for members who meet training requirements under existing regulations. The program operates under current legal authority (10 U.S.C. §2007 and 32 U.S.C. §502(a)), standardizing benefits across the service. It directly affects active-duty Air National Guard members who maintain required training schedules.
Maddy summaryThe Freedom to Heal Act of 2025 creates a new federal registration process for physicians to directly administer Schedule I investigational drugs under the "Right to Try" framework. It requires physicians to apply to the Attorney General with evidence of state compliance, manufacturer agreements, and training, and limits the amount of drugs they may possess based on approved applications. The bill mandates the Attorney General to issue interim rules within 240 days and final rules within two years covering drug delivery, storage, recordkeeping, and registration management. This affects physicians treating eligible patients with Schedule I drugs under federal Right to Try provisions, not the patients themselves.
Maddy summaryHR 6423, the HELP Copays Act, requires health insurance plans and coverage to count financial assistance from non-profits or drug manufacturers toward patient cost-sharing limits like deductibles and copayments. This directly affects patients enrolled in health insurance who receive such assistance for prescription drugs, ensuring the help they get reduces their out-of-pocket costs faster. The bill amends key health laws to mandate that these payments are included when calculating whether a patient has met their deductible or copayment threshold. The change applies to all prescription drugs, including specialty drugs and those subject to prior authorization, but does not alter how insurers manage drug access through tools like step therapy. It takes effect for plan years starting in 2026.
Maddy summaryThe Rx ACCESS Act improves prescription drug access for TRICARE beneficiaries, including military service members, retirees, and their families, by establishing fair reimbursement standards for pharmacies and expanding medication choice. It requires pharmacies to be reimbursed at actual drug costs (or the national average drug cost for certain medications) plus a standard dispensing fee, while banning hidden fees like point-of-sale charges. Starting October 1, 2026, beneficiaries can choose how they receive non-generic medications for ongoing health conditions. The law also mandates annual audits to verify reimbursement fairness and ensure pharmacy networks provide accessible care, especially in rural and underserved areas.
Building Resources and Access for Veterans' Mental Health Engagement Act of 2025 or the BRAVE Act of 2025 This bill addresses mental health services and care provided by the Department of Veterans Affairs (VA), including matters related to personnel, Vet Center administration, care for women veterans, and access to care. The bill authorizes the VA to waive the licensure or certification requirement for individual licensed professional mental health counselor appointees for a reasonable period of time. The bill also extends the Staff Sergeant Parker Gordon Fox Suicide Prevention Grant Program and increases the maximum annual grant amount. The VA must provide Vet Centers with guidance for assessing outreach activities and implement processes to periodically assess the extent to which (1) veterans and eligible members of the Armed Forces experience barriers to obtaining services at Vet Centers, and (2) Vet Center staff may encounter barriers to providing services. Among other requirements, the VA must also survey and host listening sessions with women veterans to gauge the effectiveness of the VA’s suicide prevention, lethal-means safety, and mental health resources and messaging campaigns; initiate efforts to modify the Recovery Engagement and Coordination for Health-Veterans Enhanced Treatment (REACH VET) program to incorporate risk factors weighted for women; annually offer a mental health consultation to veterans who are receiving compensation for a service-connected disability relating to a mental health diagnosis; and implement a pilot program to provide access to mental health residential treatment programs for veterans with a spinal cord injury or disorder.
Maddy summaryHRES 856 is a non-binding resolution expressing the House of Representatives' view that the U.S. Department of Agriculture (USDA) should use its existing contingency funds and interchange authority to fund the Supplemental Nutrition Assistance Program (SNAP) for November 2025. The resolution cites that the USDA holds over $5 billion in contingency funds set aside for emergencies and has legal authority under the Department of Agriculture Organic Act to transfer funds between nutrition programs to maintain SNAP benefits. This would directly support approximately 42 million people relying on SNAP, including 16 million children, 8 million seniors, 4 million people with disabilities, and 1.2 million veterans, preventing disruption during a potential funding gap. The resolution does not create new law but urges the administration to use existing resources to ensure continued food assistance.
Maddy summaryHR 6367, the Social Security Data Transparency Act, requires the Social Security Administration (SSA) to publish specific operational data monthly on a public website. It mandates detailed reporting on key metrics including first-contact resolution rates, customer satisfaction across service channels (like phone calls), 800-number performance (call wait times, success rates), processing times for old age/survivors benefits and disability claims, and system outage information. The bill also requires a live tracker for the 800-number showing real-time call wait times and caller volume. This directly affects the SSA’s reporting obligations and provides the public with transparent access to SSA service performance data. The law focuses on making SSA operations more visible through concrete, regularly updated metrics.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
Maddy summaryThis bill establishes a federal program to help low-income households pay for drinking water and wastewater services. It provides $500 million annually (2026-2030) in grants to states and tribes that already administer energy assistance programs, allowing them to cover past-due bills or other costs for households meeting specific income criteria (e.g., receiving certain federal benefits or earning ≤150% of the poverty level). The program prohibits using these funds to replace existing assistance and requires technical help to streamline eligibility. It directly affects low-income households in participating states and tribes, particularly those facing water affordability challenges.